Regulatory Resources

Clinical guidelines, MDCG guidance, FDA guidance, standards, and compliance tools

Home/Resources
All Categories
American Guidelines 221 Annex XVI Products 3 Borderline and Classification 5 Brazil (ANVISA) 1 Cardiology & Vascular 19 Cardiology & Vascular 47 China (NMPA) 1 Class I Devices 1 Clinical Investigation and Evaluation 17 Dermatology & Venereology 12 Dermatology & Venereology 7 Endocrinology, Diabetes & Metabolism 19 Endocrinology, Diabetes & Metabolism 20 EU 3 EU Regulation 2 EUDAMED 2 European Guidelines 510 Eye, ENT & Neurosensory 5 Eye, ENT & Neurosensory 7 FDA Guidance 106 Gastroenterology & Hepatology 40 Gastroenterology & Hepatology 47 Imaging & Radiology 6 Imaging & Radiology 5 IMDRF Documents 115 India (CDSCO) 1 Infectious Diseases & Microbiology 31 Infectious Diseases & Microbiology 13 Internal Medicine & Emergency 14 Internal Medicine & Emergency 4 IVDR 2 Japan (PMDA) 1 MDCG Guidance 54 MDR 8 Medical Guidelines & Recommendations 731 Medical Technology & Engineering 0 Medical Technology & Engineering 0 NB White Papers 15 Neurology & Neurosurgery 56 Neurology & Neurosurgery 12 New Technologies 7 Notified Bodies 4 Oncology & Haematology 74 Oncology & Haematology 33 Other / Transition 5 Paediatrics 16 Paediatrics 6 Post-Market Surveillance and Vigilance 5 Public Health & Primary Care 39 Public Health & Primary Care 8 Regulations 17 Rehabilitation & Geriatrics 4 Rehabilitation & Geriatrics 15 Respiratory & Intensive Care 29 Respiratory & Intensive Care 8 Rheumatology & Immunology 29 Rheumatology & Immunology 11 South Korea (MFDS) 1 Standards 51 Surgery & Orthopaedics 5 Surgery & Orthopaedics 30 Team NB Documents 50 UDI 4 UK (MHRA) 1 Umbrella & Cross-Cutting 8 Umbrella & Cross-Cutting 0 US (FDA) 8 Women's Health & Obstetrics 33 Women's Health & Obstetrics 12
1,129 resources

21 CFR Part 812 — Investigational Device Exemption (IDE)

Regulation 2024-01-01 Regulations US (FDA)

Allows investigational devices to be used in clinical studies to collect safety and effectiveness data in support of a PMA or 510(k) submission.

Download PDF

21 CFR Part 814 — Premarket Approval (PMA)

Regulation 2024-01-01 Regulations US (FDA)

Governs the most stringent FDA device pathway, required for Class III high-risk devices. Requires valid scientific evidence of safety and effectiveness, including clinical data.

Download PDF

21 CFR Part 807 Subpart E — Premarket Notification 510(k)

Regulation 2024-01-01 Regulations US (FDA)

Requires a 510(k) submission before commercial distribution of a device, demonstrating substantial equivalence to a legally marketed predicate device.

Download PDF

21 CFR Part 807 — Establishment Registration and Device Listing

Regulation 2024-01-01 Regulations US (FDA)

Requires domestic and foreign manufacturers to register with FDA and list their devices annually. Foreign manufacturers must designate a US Agent.

Download PDF

FD&C Act — Federal Food, Drug, and Cosmetic Act

Regulation 2024-01-01 Regulations US (FDA)

The foundational US law authorizing FDA to regulate medical devices. Sections 513–520 govern device classification, premarket review, postmarket requirements, and enforcement.

Download PDF

EU AI Act — Regulation (EU) 2024/1689 — Official Full Text

Regulation 2024-08-01 EU Regulations

The EU AI Act (Regulation 2024/1689) establishes a harmonised legal framework for artificial intelligence in the EU, with key implications for AI-enabled medical devices under MDR and IVDR.

Download PDF

Singapore meeting outcome statement

IMDRF Outcome statement IMDRF Documents

Outcome statement published by IMDRF.

Download PDF

Sydney meeting outcome statement

IMDRF Outcome statement IMDRF Documents

Outcome statement published by IMDRF.

Download PDF

France meeting outcome statement

IMDRF Outcome statement IMDRF Documents

Outcome statement published by IMDRF.

Download PDF

San Fransisco meeting outcome statement

IMDRF Outcome statement IMDRF Documents

Outcome statement published by IMDRF.

Download PDF
Loading more resources…
Scroll to Top